History | Baricitinib for treating moderate to severe atopic dermatitis | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 156 KB)

Published:

03 March 2021
Register of interests (PDF 140 KB)

Published:

03 March 2021

Final draft guidance

Final draft guidance
Final appraisal document (PDF 302 KB)

Published:

29 January 2021
Committee papers (PDF 5.14 MB)

Published:

29 January 2021
Public committee slides (PDF 1.22 MB)

Published:

29 January 2021

Invitation to participate

Final scope (PDF 180 KB)

Published:

17 April 2020
Final stakeholder list (PDF 182 KB)

Published:

17 April 2020
Equality Impact Assessment (Guidance development) (PDF 121 KB)

Published:

17 April 2020
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 277 KB)

Published:

17 April 2020

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope pre referral (PDF 198 KB)

Published:

28 November 2019
Draft matrix pre referral (PDF 180 KB)

Published:

28 November 2019